ARMISTICE CAPITAL, LLC

$5.6B reported 13(f) long value · latest quarter 2026-03-31 · CIK 1601086 · EDGAR ↗
sum of disclosed values for 2026-03-31; 0 positions carry a NULL value and are excluded from the sum, surfaced here rather than folded away
$5.6B
ALL retained default holdings for this (filer, period), including NULL-value ones
267
positions with no comparable holding in the prior quarter (kind new), 2026-03-31
105
positions absent from this quarter's filing after being held last quarter (kind exit), 2026-03-31 — inferred from absence, not a sale record
208
A quarter-end snapshot. Filed up to 45 days later, so this page is not current holdings and never a complete portfolio. what a 13F is — and is not ↓ methodology §13F ↗
FILING WINDOW OPEN
Quarter 2026-09-30: the 13F window is open until 2026-11-16. Rankings and QoQ moves that touch this quarter are provisional by construction — filers who have not yet reported are not zeros.

Position changes — into 2026-03-31

by shares · Δ value · filing link · how changes are classified §
Period
Position changes into quarter 2026-03-31
position matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match identity_reconciled_by_cusipthe reported share count is unchanged across the pair; this build's data classified the change from its reported value; builds from 2026-09-10 on read it as NO CHANGE classified_by_value · EXIT = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · NO CHANGE = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an ADD or a TRIM (NEW / ADD / TRIM / EXIT / NO CHANGE) · NO PRIOR = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stakederived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zeroreported unit changed across the pair (SH↔PRN); the share delta is withheld rather than fabricated shares_unit_mismatchPrev valueCurr valuePrev sharesCurr shares
position key pos:11570 · issuer key iss:1599 TR UNIT PUTTRIM−$680M−900,000$2.0B$1.4B3,000,0002,100,000
position key pos:15702 · issuer key iss:1012 RUSSELL 2000 ETF PUTTRIM−$1.1B−4,600,000$2.0B$868M8,100,0003,500,000
position key pos:17702 · issuer key iss:1818 COMADD+$1.7M+1,133,526$144M$146M3,763,8914,897,417
position key pos:17611 · issuer key iss:1399 COMTRIM−$71.5M−727,420$213M$141M2,801,8692,074,449
position key pos:14357 · issuer key iss:1170 COMTRIM−$16.2M−1,122$155M$139M265,705264,583
position key pos:12465 · issuer key iss:548 COM NEW CALLADD+$16.7M+200,000$95.3M$112M1,500,0001,700,000
position key pos:13165 · issuer key cusip6:00847X COM CALLADD+$26.6M+200,000$81.7M$108M3,000,0003,200,000
position key sid:sec:prov:38b7ce53f517b4f397d48b58dc3386d9 · issuer key cusip6:868459 COMTRIM−$39.4M−868,653$137M$98.0M2,764,0001,895,347
position key pos:11462 · issuer key iss:1296 COMTRIM−$21.0M−96,240$116M$95.4M820,240724,000
position key pos:13165 · issuer key cusip6:00847X COMTRIM+$9.2M−320,000$82.6M$91.9M3,036,0002,716,000
position key sid:sec:prov:c0680e314bfe2d1131f5c3d642c67920 · issuer key cusip6:45258J COMTRIM−$57.5M−2,182,239$146M$88.6M5,747,1553,564,916
position key pos:10327 · issuer key iss:780 COMTRIM−$14.5M−202,693$79.0M$64.5M1,296,0001,093,307
position key pos:15877 · issuer key iss:961 COMTRIM−$46.6M−441,285$108M$61.8M1,098,102656,817
position key pos:13703 · issuer key iss:619 COMTRIM−$6.0M−74,598$63.6M$57.6M3,249,7083,175,110
position key pos:14175 · issuer key iss:95 COMTRIM−$30.3M−105,496$84.9M$54.6M367,633262,137
position key pos:13370 · issuer key iss:1010 COM CL ATRIM−$1.3M−997,000$54.0M$52.7M16,025,00015,028,000
position key pos:12465 · issuer key iss:548 COM NEWTRIM−$12.7M−228,228$63.1M$50.4M992,766764,538
position key sid:sec:prov:c0680e314bfe2d1131f5c3d642c67920 · issuer key cusip6:45258J COM CALLADD+$28.1M+1,150,000$19.1M$47.2M750,0001,900,000
position key pos:13461 · issuer key iss:881 COMADD+$26.8M+1,124,000$18.7M$45.5M500,0001,624,000
position key pos:15125 · issuer key iss:1798 COMADD+$8.6M+28,653$36.4M$45.0M62,83891,491
position key sid:sec:prov:8689270ade82a464b05b5b23e79f9006 · issuer key cusip6:640268 COM NEWTRIM+$16.4M−18,000$25.2M$41.6M596,000578,000
position key pos:16115 · issuer key iss:1869 COMNEW+$40.0M+148,000$0$40.0M—148,000
position key pos:12696 · issuer key iss:1845 COMADD+$14.2M+236,026$23.1M$37.3M282,734518,760
position key pos:15541 · issuer key iss:958 ADSADD−$2.3M+90,000$38.1M$35.8M1,098,0001,188,000
position key pos:11762 · issuer key iss:569 COMTRIM−$48.6M−4,298,000$83.4M$34.8M7,298,0003,000,000
position key sid:sec:prov:fd7b61c158906c86402255a51c19f819 · issuer key cusip6:766559 COMADD−$1.2M+444,000$35.8M$34.6M836,0001,280,000
position key pos:12161 · issuer key iss:587 COMADD−$5.4M+36,609$39.7M$34.3M499,391536,000
position key pos:15142 · issuer key iss:89 CAP STK CL ATRIM−$27.4M−77,906$61.5M$34.1M196,420118,514
position key sid:sec:prov:d00159df48fd34cc806ae902a076ba0a · issuer key cusip6:603170 COMADD+$7.3M+499,965$24.5M$31.9M676,0351,176,000
position key pos:14303 · issuer key iss:927 COMADD+$4.1M+60,583$27.3M$31.4M68,000128,583
position key sid:sec:prov:2dd39154b043cf25ad12f54df878e5cb · issuer key cusip6:68752M COMADD−$9.2M+52,000$40.1M$31.0M2,648,0002,700,000
position key sid:sec:prov:44dcd89ab4e3fa904b2bfbfadeb83d25 · issuer key cusip6:50127T COMTRIM−$20.9M−1,200,000$51.3M$30.4M4,936,0003,736,000
position key pos:10741 · issuer key iss:199 COMTRIM−$7.9M−1,200,000$35.9M$28.0M3,200,0002,000,000
position key pos:15140 · issuer key iss:1537 COMTRIM−$36.9M−47,874$64.8M$27.9M84,00036,126
position key pos:14053 · issuer key iss:73 COMADD+$15.2M+81,855$11.9M$27.1M76,104157,959
position key pos:17611 · issuer key iss:1399 COM CALLNEW+$26.6M+390,000$0$26.6M—390,000
position key pos:15737 · issuer key iss:1247 CL AADD+$5.6M+58,152$20.6M$26.3M49,144107,296
position key pos:15694 · issuer key iss:72 SPONSORED ADSTRIM−$21.2M−115,100$46.8M$25.6M319,100204,000
position key pos:15409 · issuer key iss:1212 COM CL AADD+$22.7M+506,841$2.4M$25.1M58,016564,857
position key pos:10126 · issuer key cusip6:483497 COMADD+$12.0M+436,000$12.9M$24.9M800,0001,236,000
position key pos:16528 · issuer key iss:559 CL A COMTRIM−$8.6M−35,973$33.3M$24.6M244,537208,564
position key pos:10550 · issuer key iss:929 COMADD+$6.1M+69,582$18.4M$24.5M71,697141,279
position key pos:11533 · issuer key iss:1645 CL ATRIM−$11.9M−524,370$36.3M$24.4M2,422,2191,897,849
position key pos:13163 · issuer key cusip6:92337C COM NEWADD−$3.0M+1,056,000$27.3M$24.3M3,536,0004,592,000
position key pos:10134 · issuer key iss:751 COMTRIM−$15.9M−408,000$40.1M$24.2M2,000,0001,592,000
position key pos:16805 · issuer key iss:997 COM NEWTRIM−$10.6M−9,030$34.6M$24.0M61,07352,043
position key sid:sec:prov:0e98b3abdccb3abb7f7b05b1196945d8 · issuer key cusip6:398438 SP ADR REP B NVTADD−$1.9M+220,000$25.9M$24.0M2,768,0002,988,000
position key pos:16646 · issuer key iss:1429 COMTRIM−$21.9M−1,518,000$45.7M$23.7M3,096,0001,578,000
position key pos:11739 · issuer key iss:1687 COM NEWADD+$8.3M+588,000$14.7M$23.0M2,612,0003,200,000
position key sid:sec:prov:431d99b61e91bc00d72171223c54fba0 · issuer key cusip6:37637K CLASS A COMADD−$10.0M+169,739$32.2M$22.3M858,9251,028,664
position key sid:sec:prov:0cba59ee844ea8b6e5b356f9157cdead · issuer key cusip6:05280R SPON ADSTRIM−$13.0M−1,700,000$34.8M$21.8M17,500,00015,800,000
position key pos:11533 · issuer key iss:1645 CL A CALLTRIM−$26.7M−1,550,000$48.0M$21.3M3,200,0001,650,000
position key pos:13648 · issuer key iss:131 COMADD−$577K+169,000$21.8M$21.3M1,700,0001,869,000
position key pos:11358 · issuer key iss:173 COMADD−$381K+178,000$21.3M$21.0M1,800,0001,978,000
position key pos:17467 · issuer key iss:1751 SPONSORED ADSADD+$5.5M+11,254$15.2M$20.7M50,00061,254
position key sid:sec:prov:d8f1dce881f876173d775baaae476159 · issuer key cusip6:02157Q COM SHSTRIM−$6.8M−624,000$27.3M$20.5M1,536,000912,000
position key sid:sec:prov:7238aa41158ebd8084353f3976d45d0e · issuer key cusip6:29272W COMADD−$902K+164,000$20.6M$19.7M1,036,0001,200,000
position key pos:10134 · issuer key iss:751 COM CALLTRIM−$17.1M−550,000$36.1M$19.0M1,800,0001,250,000
position key pos:11390 · issuer key iss:720 CL ANEW+$18.6M+32,594$0$18.6M—32,594
position key sid:sec:prov:adc22e9a1524ab89aa68e69a21eb8d93 · issuer key cusip6:35104E COMADD+$4.1M+64,000$14.5M$18.6M1,936,0002,000,000
position key pos:11825 · issuer key iss:1225 COMTRIM−$39.1M−69,477$57.2M$18.1M118,33748,860
position key pos:16440 · issuer key iss:637 COMTRIM−$5.7M−52,643$23.7M$18.0M277,478224,835
position key pos:13025 · issuer key iss:1992 COMTRIM−$3.6M−2,645$21.2M$17.6M176,190173,545
position key sid:sec:prov:2cf06ac89e78fe7c69baaccedd98a9c7 · issuer key cusip6:556099 COMTRIM+$7.2M−312,000$10.2M$17.4M6,324,0006,012,000
position key pos:17712 · issuer key iss:1630 COMADD+$7.8M+136,959$8.8M$16.6M200,000336,959
position key pos:16739 · issuer key iss:260 SPONSORED ADSADD−$7.1M+162,000$22.9M$15.8M3,236,0003,398,000
position key sid:sec:prov:d26d9a2073ff14f944fae9a38cd0684a · issuer key cusip6:153527 CL A NON-VTGNEW+$15.5M+478,000$0$15.5M—478,000
position key pos:15921 · issuer key iss:1110 CL AADD−$181K+25,718$15.6M$15.4M151,295177,013
position key pos:11148 · issuer key iss:1805 CL AADD+$7.2M+349,718$8.1M$15.3M227,753577,471
position key pos:10720 · issuer key iss:1622 SPONSORED ADRTRIM−$18.3M−376,000$32.8M$14.5M676,000300,000
position key pos:14819 · issuer key iss:262 COMADD−$443K+103,519$14.8M$14.4M271,389374,908
position key pos:11654 · issuer key iss:1847 CL ATRIM−$10.7M−239,897$25.0M$14.3M1,524,6171,284,720
position key pos:16646 · issuer key iss:1429 COM CALLNEW+$13.5M+900,000$0$13.5M—900,000
position key sid:sec:prov:049c2d4f45ba193716199e4b705e328c · issuer key cusip6:92915B COMTRIM−$2.2M−500,000$15.7M$13.5M4,000,0003,500,000
position key pos:12465 · issuer key iss:548 COM NEW PUTNEW+$13.2M+200,000$0$13.2M—200,000
position key pos:16076 · issuer key iss:826 SPONSORED ADRTRIM−$36.0M−764,000$49.0M$13.0M1,000,000236,000
position key pos:15327 · issuer key iss:1780 COMADD+$7.5M+15,630$5.5M$13.0M28,30243,932
position key pos:14626 · issuer key iss:536 COMTRIM−$3.4M−35,757$16.3M$12.8M190,350154,593
position key pos:13891 · issuer key iss:1313 CL BTRIM−$12.7M−158,169$25.1M$12.5M394,709236,540
position key pos:15008 · issuer key iss:318 COMTRIM−$7.7M−167,442$20.1M$12.4M372,466205,024
position key sid:sec:prov:c6f0567aff349dfe2dab4a6ee5ba8988 · issuer key cusip6:92337R CL ATRIM−$21.1M−355,632$33.1M$12.0M653,796298,164
position key pos:12072 · issuer key iss:310 COM NEWADD−$634K+328,000$12.5M$11.9M1,000,0001,328,000
position key pos:15111 · issuer key iss:2070 SHSNEW+$11.6M+658,000$0$11.6M—658,000
position key pos:11841 · issuer key iss:2300 SHS CLASS ATRIM−$11.2M−159,421$22.4M$11.2M267,421108,000
position key pos:12682 · issuer key iss:1998 COMNEW+$11.1M+1,909,838$0$11.1M—1,909,838
position key pos:16039 · issuer key iss:686 COMNEW+$10.8M+3,930,125$0$10.8M—3,930,125
position key pos:16495 · issuer key iss:1005 COMNEW+$10.4M+60,884$0$10.4M—60,884
position key pos:10663 · issuer key iss:1575 COMTRIM−$9.6M−63,126$20.0M$10.4M111,03447,908
position key pos:15642 · issuer key iss:1334 COMTRIM−$1.6M−4,686$11.9M$10.3M63,95559,269
position key sid:sec:prov:670e7a62cbda3ccc5db947ec9ee5e2d7 · issuer key cusip6:800677 COMNEW+$10.0M+40,400,067$0$10.0M—40,400,067
position key pos:18143 · issuer key iss:982 COMADD+$5.3M+101,059$4.5M$9.9M122,936223,995
position key pos:16095 · issuer key iss:151 COM CL AADD−$5.3M+2,160$15.0M$9.7M22,26224,422
position key pos:17607 · issuer key iss:1988 CL ATRIM−$10.6M−19,898$20.2M$9.6M93,89373,995
position key pos:10882 · issuer key iss:1533 CL ATRIM−$8.2M−6,600$17.6M$9.4M76,60070,000
position key sid:sec:prov:3402bbe7c4ba34aeef0c97588550f290 · issuer key cusip6:641288 COMTRIM−$3.1M−100,000$12.2M$9.1M792,000692,000
position key sid:sec:prov:37f8d7b8f8c97e91dcf78ef12d0dd5a9 · issuer key cusip6:G9TY5A CLASS A ORD SHSTRIM+$792K−53,000$8.2M$9.0M1,560,0001,507,000
position key pos:15851 · issuer key iss:1426 COMADD+$1.1M+78,435$7.9M$9.0M131,994210,429
position key pos:12900 · issuer key iss:808 COMNEW+$8.8M+44,902$0$8.8M—44,902
position key pos:16356 · issuer key iss:795 COMMON STOCKTRIM−$56.5M−673,711$65.0M$8.4M792,000118,289
position key pos:15221 · issuer key iss:1228 COMNEW+$7.9M+23,293$0$7.9M—23,293

Flags: no row carries a flag.

1–20 of the 100 changes on this page

1–100 of 452 changes
Mark-to-market only (no share change) · 17

Positions whose share count is identical in both quarters; the value changed with price, not with a decision.

Positions held with no share change into quarter 2026-03-31
position matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match identity_reconciled_by_cusipthe reported share count is unchanged across the pair; this build's data classified the change from its reported value; builds from 2026-09-10 on read it as NO CHANGE classified_by_value · EXIT = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · NO CHANGE = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an ADD or a TRIM (NEW / ADD / TRIM / EXIT / NO CHANGE) · NO PRIOR = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stakederived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zeroreported unit changed across the pair (SH↔PRN); the share delta is withheld rather than fabricated shares_unit_mismatchPrev valueCurr valuePrev sharesCurr shares
position key sid:sec:prov:fd61a14f8c16900d70648b14bc187bfb · issuer key cusip6:05463X COMNO CHANGE+$374K0$30.6M$31.0M936,000936,000
position key sid:sec:prov:c08a16c0af7981adc90fd977ca92e202 · issuer key cusip6:89455T COMNO CHANGE−$7.1M0$15.6M$8.5M6,364,0006,364,000
position key sid:sec:prov:6ea21d63f42e751642c219cdf4c44eee · issuer key cusip6:31572Q COM NEWNO CHANGE−$800K0$3.5M$2.7M400,000400,000
position key sid:sec:prov:2f108e284193cdde1e047a105f455099 · issuer key cusip6:92552R COMNO CHANGE+$140K0$1.6M$1.7M47,50047,500
position key sid:sec:prov:ad5917478a4dafa1e60c5d41ce7ed355 · issuer key cusip6:M68057 *W EXP 02/04/202NO CHANGE+$39.1K0$151K$190K1,261,0581,261,058
position key sid:sec:prov:0fcb62a90d06d9c6fb59e4e7c4720e95 · issuer key cusip6:09074F *W EXP 08/08/203NO CHANGE+$26.5K0$129K$155K500,000500,000
position key sid:sec:prov:45a88905bf6b015b2c4bec16254bc985 · issuer key cusip6:42238H *W EXP 10/31/202NO CHANGE−$100.0K0$160K$60.1K500,000500,000
position key sid:sec:prov:dc991f580e23059100e0575b143cb1a9 · issuer key cusip6:58471K *W EXP 11/15/202NO CHANGE+$9.1K0$48.5K$57.6K60,60060,600
position key sid:sec:prov:bcc0a1a3fc7e67edbf27fd39d5bbecc3 · issuer key cusip6:65344E *W EXP 12/27/202NO CHANGE−$96.4K0$129K$32.9K550,000550,000
position key sid:sec:prov:32efbe47543ba5bc495e7517969f678b · issuer key cusip6:Q56120 *W EXP 03/29/202NO CHANGE+$4.7K0$26.8K$31.5K12,12112,121
position key sid:sec:prov:6bb2198a93ff3056435b88f9771811f5 · issuer key cusip6:68277K *W EXP 01/02/202NO CHANGE−$9.5K0$34.0K$24.5K400,000400,000
position key sid:sec:prov:a725fdbdd13bddb0eb49815a7b7963c8 · issuer key cusip6:86260J *W EXP 99/99/999NO CHANGE−$7630$21.8K$21.0K545,000545,000
position key sid:sec:prov:5ec1fa1ce02c2e96f77055e523182986 · issuer key cusip6:G3302D *W EXP 99/99/999NO CHANGE−$4.1K0$10.0K$6.0K186,666186,666
position key sid:sec:prov:1a4aa59a6952de3e16f2b5c3887ad6f8 · issuer key cusip6:74102L *W EXP 01/24/202NO CHANGE−$2.0K0$6.0K$4.0K200,000200,000
position key sid:sec:prov:18d4df07d1f7580af8d465c7199fb67e · issuer key cusip6:46583A *W EXP 04/01/202NO CHANGE−$1.5K0$2.2K$74518,12518,125
position key sid:sec:prov:6e8bc748698a3016bf2d4f2529e8ae67 · issuer key cusip6:70261F *W EXP 08/12/202NO CHANGE−$1400$705$56550,00050,000
position key sid:sec:prov:d28b9d4819261519edf3475433d30502 · issuer key cusip6:88066N *W EXP 06/16/202NO CHANGE−$560$234$17822,25022,250

Flags: no row carries a flag.

Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt.
Truncated by Public Filings. Changes compare every position with a security identifier, new and exited included; holdings without one are counted, not compared. methodology §13F ↗

Reported positions — 2026-03-31

1–100 of 252 issuers · $5.6B disclosed value over 267 rows · 0 undisclosed-value rows
View
This build carries one quarter for this manager: 2026-03-31. Notable managers carry four published quarters, others two.
Positions ARMISTICE CAPITAL, LLC reported for the quarter ended 2026-03-31, as that filer reported them
This list carries reported issuer names and security identities, without a dated ticker mapping. Symbols are not inferred from names.a position composed from a base filing plus NEW-HOLDINGS amendments keeps every source row here; the composition's latest filed date is the one shown served from this build's published holdings (derived from the filer's own reported rows); every row resolves to its filingShare of total reported value, calculated only when the full position list has disclosed values. This is 13F long value, not total assets.value undisclosed on the filing: retained and counted, excluded from sums, never shown as $0SharesWt
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)STATE STR SPDR S&P 500 ETF T · TR UNIT · PUT CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$1.4B2,100,00024.3%
—ISHARES TR · RUSSELL 2000 ETF · PUT CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$868M3,500,00015.4%
—AGIOS PHARMACEUTICALS INC
2 positions · 2 reported rows
Rows ARMISTICE CAPITAL, LLC reported for AGIOS PHARMACEUTICALS INC, as it reported them
AGIOS PHARMACEUTICALS INC · COM · CALL CUSIP — $108M3,200,000
AGIOS PHARMACEUTICALS INC · COM CUSIP — $91.9M2,716,000
ticker not yet mapped
$200M5,916,0003.6%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)CYTOKINETICS INC
3 positions · 4 reported rows
Rows ARMISTICE CAPITAL, LLC reported for CYTOKINETICS INC, as it reported them
CYTOKINETICS INC · COM NEW · CALL CUSIP — $56.0M850,000
CYTOKINETICS INC · COM NEW · CALL CUSIP — $56.0M850,000
CYTOKINETICS INC · COM NEW CUSIP — $50.4M764,538
CYTOKINETICS INC · COM NEW · PUT CUSIP — $13.2M200,000
$176M2,664,5383.1%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)PTC THERAPEUTICS INC
2 positions · 2 reported rows
Rows ARMISTICE CAPITAL, LLC reported for PTC THERAPEUTICS INC, as it reported them
PTC THERAPEUTICS INC · COM CUSIP — $141M2,074,449
PTC THERAPEUTICS INC · COM · CALL CUSIP — $26.6M390,000
$168M2,464,4493.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)TRAVERE THERAPEUTICS INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$146M4,897,4172.6%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)MADRIGAL PHARMACEUTICALS INC
1 position · 3 reported rows
Rows ARMISTICE CAPITAL, LLC reported for MADRIGAL PHARMACEUTICALS INC, as it reported them
MADRIGAL PHARMACEUTICALS INC · COM CUSIP — $52.3M100,000
MADRIGAL PHARMACEUTICALS INC · COM CUSIP — $52.1M99,583
MADRIGAL PHARMACEUTICALS INC · COM CUSIP — $34.0M65,000
$139M264,5832.5%
—IMMUNOVANT INC
2 positions · 4 reported rows
Rows ARMISTICE CAPITAL, LLC reported for IMMUNOVANT INC, as it reported them
IMMUNOVANT INC · COM CUSIP 45258J102 $88.6M3,564,916
IMMUNOVANT INC · COM · CALL CUSIP 45258J102 $19.9M800,000
IMMUNOVANT INC · COM · CALL CUSIP 45258J102 $17.4M700,000
IMMUNOVANT INC · COM · CALL CUSIP 45258J102 $9.9M400,000
ticker not yet mapped
$136M5,464,9162.4%
—SUPERNUS PHARMACEUTICALS · COM CUSIP 868459108
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$98.0M1,895,3471.7%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)NEUROCRINE BIOSCIENCES INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$95.4M724,0001.7%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)FRESHPET INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$64.5M1,093,3071.1%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)INCYTE CORP · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$61.8M656,8171.1%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)DYNE THERAPEUTICS INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$57.6M3,175,1101.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)AMAZON COM INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$54.6M262,1371.0%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)IRONWOOD PHARMACEUTICALS INC · COM CL A CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$52.7M15,028,0000.9%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)SENTINELONE INC
2 positions · 3 reported rows
Rows ARMISTICE CAPITAL, LLC reported for SENTINELONE INC, as it reported them
SENTINELONE INC · CL A CUSIP — $24.4M1,897,849
SENTINELONE INC · CL A · CALL CUSIP — $12.9M1,000,000
SENTINELONE INC · CL A · CALL CUSIP — $8.4M650,000
$45.7M3,547,8490.8%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)HARMONY BIOSCIENCES HLDGS IN · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$45.5M1,624,0000.8%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)THERMO FISHER SCIENTIFIC INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$45.0M91,4910.8%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)FIVE9 INC
2 positions · 2 reported rows
Rows ARMISTICE CAPITAL, LLC reported for FIVE9 INC, as it reported them
FIVE9 INC · COM CUSIP — $24.2M1,592,000
FIVE9 INC · COM · CALL CUSIP — $19.0M1,250,000
$43.1M2,842,0000.8%
—NEKTAR THERAPEUTICS · COM NEW CUSIP 640268306
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$41.6M578,0000.7%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)UNITEDHEALTH GROUP INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$40.0M148,0000.7%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)UBER TECHNOLOGIES INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$37.3M518,7600.7%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)PENN ENTERTAINMENT INC
2 positions · 2 reported rows
Rows ARMISTICE CAPITAL, LLC reported for PENN ENTERTAINMENT INC, as it reported them
PENN ENTERTAINMENT INC · COM CUSIP — $23.7M1,578,000
PENN ENTERTAINMENT INC · COM · CALL CUSIP — $13.5M900,000
$37.2M2,478,0000.7%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)IMMUNOCORE HLDGS PLC · ADS CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$35.8M1,188,0000.6%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)DENTSPLY SIRONA INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$34.8M3,000,0000.6%
—RIGEL PHARMACEUTICALS INC · COM CUSIP 766559702
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$34.6M1,280,0000.6%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)DISC MEDICINE INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$34.3M536,0000.6%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)ALPHABET INC · CAP STK CL A CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$34.1M118,5140.6%
—MINERALYS THERAPEUTICS INC · COM CUSIP 603170101
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$31.9M1,176,0000.6%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)HUBSPOT INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$31.4M128,5830.6%
—AXOGEN INC · COM CUSIP 05463X106
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$31.0M936,0000.6%
—ORTHOFIX MED INC · COM CUSIP 68752M108
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$31.0M2,700,0000.6%
—KURA ONCOLOGY INC · COM CUSIP 50127T109
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$30.4M3,736,0000.5%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)AVANOS MED INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$28.0M2,000,0000.5%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)REGENERON PHARMACEUTICALS · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$27.9M36,1260.5%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)ALIGN TECHNOLOGY INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$27.1M157,9590.5%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)MONGODB INC · CL A CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$26.3M107,2960.5%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)ALIBABA GROUP HLDG LTD · SPONSORED ADS CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$25.6M204,0000.5%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)MEDLINE INC · COM CL A CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$25.1M564,8570.4%
—KALVISTA PHARMACEUTICALS INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$24.9M1,236,0000.4%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)DATADOG INC · CL A COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$24.6M208,5640.4%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)HUMANA INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$24.5M141,2790.4%
—VERASTEM INC · COM NEW CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$24.3M4,592,0000.4%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)INTUITIVE SURGICAL INC · COM NEW CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$24.0M52,0430.4%
—GRIFOLS S A · SP ADR REP B NVT CUSIP 398438408
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$24.0M2,988,0000.4%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)SOLID BIOSCIENCES INC · COM NEW CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$23.0M3,200,0000.4%
—GITLAB INC · CLASS A COM CUSIP 37637K108
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$22.3M1,028,6640.4%
—AUTOLUS THERAPEUTICS LTD · SPON ADS CUSIP 05280R100
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$21.8M15,800,0000.4%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)ANGIODYNAMICS INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$21.3M1,869,0000.4%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)ARVINAS INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$21.0M1,978,0000.4%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)TAIWAN SEMICONDUCTOR MANUFAC · SPONSORED ADS CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$20.7M61,2540.4%
—ALTO NEUROSCIENCE INC · COM SHS CUSIP 02157Q109
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$20.5M912,0000.4%
—ENERGIZER HLDGS INC · COM CUSIP 29272W109
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$19.7M1,200,0000.4%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)META PLATFORMS INC · CL A CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$18.6M32,5940.3%
—4D MOLECULAR THERAPEUTICS IN · COM CUSIP 35104E100
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$18.6M2,000,0000.3%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)MICROSOFT CORP · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$18.1M48,8600.3%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)EDWARDS LIFESCIENCES CORP · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$18.0M224,8350.3%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)WYNN RESORTS LTD · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$17.6M173,5450.3%
—MACROGENICS INC · COM CUSIP 556099109
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$17.4M6,012,0000.3%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)SCHOLAR ROCK HLDG CORP · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$16.6M336,9590.3%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)BICYCLE THERAPEUTICS PLC · SPONSORED ADS CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$15.8M3,398,0000.3%
—CENTRAL GARDEN & PET CO · CL A NON-VTG CUSIP 153527205
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$15.5M478,0000.3%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)LENNAR CORP · CL A CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$15.4M177,0130.3%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)TOAST INC · CL A CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$15.3M577,4710.3%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)SANOFI SA · SPONSORED ADR CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$14.5M300,0000.3%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)BILL HOLDINGS INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$14.4M374,9080.3%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)UIPATH INC · CL A CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$14.3M1,284,7200.3%
—VOYAGER THERAPEUTICS INC · COM CUSIP 92915B106
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$13.5M3,500,0000.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)GSK PLC · SPONSORED ADR CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$13.0M236,0000.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)TERADYNE INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$13.0M43,9320.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)CROCS INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$12.8M154,5930.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)NIKE INC · CL B CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$12.5M236,5400.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)BRISTOL-MYERS SQUIBB CO · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$12.4M205,0240.2%
—VERA THERAPEUTICS INC · CL A CUSIP 92337R101
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$12.0M298,1640.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)BRIDGEBIO ONCOLOGY THERAPEUT · COM NEW CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$11.9M1,328,0000.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)CAPRI HOLDINGS LIMITED · SHS CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$11.6M658,0000.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)NEBIUS GROUP N.V. · SHS CLASS A CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$11.2M108,0000.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)XERIS BIOPHARMA HOLDINGS INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$11.1M1,909,8380.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)ESPERION THERAPEUTICS INC NE · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$10.8M3,930,1250.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)IQVIA HLDGS INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$10.4M60,8840.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)ROSS STORES INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$10.4M47,9080.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)NVIDIA CORPORATION · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$10.3M59,2690.2%
—SANGAMO THERAPEUTICS INC · COM CUSIP 800677106
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$10.0M40,400,0670.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)INTEL CORP · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$9.9M223,9950.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)APPLOVIN CORP · COM CL A CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$9.7M24,4220.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)WORKDAY INC · CL A CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$9.6M73,9950.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)REDDIT INC · CL A CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$9.4M70,0000.2%
—NEUROPACE INC · COM CUSIP 641288105
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$9.1M692,0000.2%
—ZURA BIO LTD · CLASS A ORD SHS CUSIP G9TY5A101
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$9.0M1,507,0000.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)PEGASYSTEMS INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$9.0M210,4290.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)GENERAC HLDGS INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$8.8M44,9020.2%
—TREACE MED CONCEPTS INC · COM CUSIP 89455T109
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$8.5M6,364,0000.2%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)GE HEALTHCARE TECHNOLOGIES I · COMMON STOCK CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$8.4M118,2890.1%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)MICRON TECHNOLOGY INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$7.9M23,2930.1%
—TENAX THERAPEUTICS INC · COM NEW CUSIP 88032L605
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$7.7M478,8270.1%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)NUVATION BIO INC · COM CL A CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$7.4M1,736,0000.1%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)INOGEN INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$7.4M1,200,0000.1%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)OREILLY AUTOMOTIVE INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$7.2M78,1030.1%
verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)KYMERA THERAPEUTICS INC · COM CUSIP —
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
$7.0M83,8760.1%
—DOGWOOD THERAPEUTICS INC · COM NEW CUSIP 92829J203
quarter ended 2026-03-31 filed filed 2026-05-15 +45d
ticker not yet mapped
$6.9M3,280,0000.1%

1–20 of the 100 issuers on this page

Change kind and share change are in Position changes above; Congress overlap is planned.

1–100 of 252 issuers · page 1 of 3
One line per issuer, largest first; a row with no issuer key stands on its own line. Open a line for its rows as this filer reported them. The list holds every row this filer reported for the quarter. Issuer totals on the holders pages count each manager's own report once; that never removes a row here. how positions are grouped ↗

Book shape

2026-03-31 · concentration · vs tracked median · tick = median
Top-25 concentration
69.7%below median 80.0%
Concentration index
886 bpsabove median 446 bps
Positions with value
267 / 267median book 97.5 positions

Concentration uses reported 13F long value, not total assets. The index is withheld when any position lacks a value. Medians are over the 8,748 tracked filers with a 2026-03-31 book; the index median over the 8,662 with a complete book.

holdings whose <value> did not parse — retained and counted, never zero-filled: 0 · share of the period's disclosed value held in the top-N positions; denominator is reported 13F value, not total assets: 69.7% · integer Herfindahl–Hirschman index in basis points over disclosed position values: 886 · QoQ moves: 469

Filing history

AVAILABLE QUARTERS
Available filing periods
PeriodSource
2026-03-31EDGAR ↗

PLANNED sector rotation · Congress overlap · signals for this filer

Complete source filings on SEC EDGAR

The complete filing on EDGAR.

The position list above is served from the published Public Filings build, each position as this filer reported it; where the page cannot embed every reported row, the list says how many it leaves out. This block is provenance, not a substitute: the filing itself is the record, and it is one click away. Public Filings decided on 2026-08-01 to serve this list from its published build; filings newer than this build are on EDGAR.

Open ARMISTICE CAPITAL, LLC's 13F filings on SEC EDGAR ↗
Notes on this data

Quarter-end holdings as filed

Explore the full published position list and its source filing. This record excludes the manager’s cash, shorts and non-13(f) assets.

Compare consecutive quarters

Position changes retain the producer’s classification and comparability flags. Share counts and reported values describe different changes.

A snapshot, not current holdings

Use the quarter selector to inspect available periods. Unknown values stay unknown and each table states its coverage.

A 13F is a quarterly, long-only snapshot filed up to 45 days late — not current holdings. what a 13F covers ↗

13F reports cover LONG positions in Section 13(f) securities (US exchange-traded equities plus reportable options, warrants, certain convertibles) held by managers with at least $100M in such securities — so managers below that threshold are absent entirely. No short positions, no cash, no non-13(f) assets — not a full portfolio, and not a census of institutional ownership.

Positions are quarter-end snapshots filed up to 45 days late — not current holdings. A position may have been changed or closed before you ever see it, and is older still by however long ago that quarter ended.

Values are the manager's stated market value at quarter-end in era-dependent units (whole dollars for form versions effective 2023-01-03 onward, thousands before), normalized here to whole dollars with unit_basis carried on every record.

Affiliated managers may report the same position (otherManager), so one position can appear under more than one filer.

Positions under confidential treatment may be omitted until a later amendment discloses them.

These are disclosures, not investment advice (ARCHITECTURE.md §5.2 / M2-CONTRACT §5).